Protocol for a randomised controlled trial of ketamine versus ketamine and behavioural activation therapy for adults with treatment-resistant depression in the community

Introduction Although short-term benefits follow parenteral ketamine for treatment-resistant major depressive disorder (TR-MDD), there are challenges that prevent routine use of ketamine by clinicians. These include acute dissociative effects of parenteral ketamine, high relapse rates following keta...

Full description

Bibliographic Details

Published in:	BMJ Open
Main Authors:	Christopher Frampton, Richard Porter, Greg Murray, Jennifer Jordan, Ben Beaglehole, Paul Glue, Katie Douglas, Cameron James Lacey, Aroha de Bie, Charlie Mentzel, Bridgette Thwaites, Jenni Manuel
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2024-05-01
Online Access:	https://bmjopen.bmj.com/content/14/5/e084844.full